Arcutis Biotherapeutics (ARQT) Stock Chart & Stock Price History $14.86 +1.29 (+9.51%) (As of 12/17/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Arcutis Biotherapeutics Stock Price Performance 5 Day Performance+17.10%1 Month Performance+57.58%3 Month Performance+42.88%6 Month Performance+82.33%Year-To-Date Performance+360.06%1 Year Performance+485.04% Receive ARQT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Forbes rich list released… #1 to be assassinated? (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now ARQT Stock Chart for Wednesday, December, 18, 2024 ARQT Chart by TradingView Arcutis Biotherapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$13.57$14.86+9.51%$14.93$13.453.87 million shs$1.74 billion12/16/2024$12.69$13.57+6.93%$13.60$12.631.96 million shs$1.59 billion12/13/2024$12.25$12.69+3.59%$13.39$12.122.72 million shs$1.49 billion12/12/2024$12.77$12.25-4.07%$12.89$12.071.82 million shs$1.43 billion12/11/2024$13.15$12.77-2.89%$13.48$12.301.72 million shs$1.49 billion12/10/2024$12.58$13.15+4.53%$13.24$12.252.23 million shs$1.54 billion Get the Latest News and Ratings for ARQT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$12.40$12.58+1.45%$12.93$12.331.40 million shs$1.47 billion12/06/2024$12.31$12.40+0.73%$12.98$12.151.51 million shs$1.45 billion12/05/2024$12.61$12.31-2.38%$12.91$12.111.21 million shs$1.44 billion12/04/2024$12.27$12.61+2.77%$12.71$12.101.89 million shs$1.48 billion12/03/2024$12.42$12.27-1.17%$12.59$12.211.46 million shs$1.44 billion12/02/2024$13.04$12.42-4.79%$13.00$12.232.25 million shs$1.45 billion11/29/2024$11.71$13.04+11.36%$13.39$11.672.56 million shs$1.53 billion11/28/2024$11.71$11.71$11.88$11.381.70 million shs$1.37 billion11/27/2024$11.51$11.71+1.74%$11.88$11.381.70 million shs$1.37 billion11/26/2024$10.77$11.51+6.87%$11.64$10.572.65 million shs$1.35 billion11/25/2024$10.14$10.77+6.21%$11.10$10.212.27 million shs$1.26 billion11/22/2024$10.31$10.14-1.65%$10.29$10.051.11 million shs$1.19 billion11/21/2024$10.18$10.31+1.28%$10.72$10.031.06 million shs$1.21 billion11/20/2024$10.09$10.18+0.89%$10.42$9.931.03 million shs$1.19 billion11/19/2024$9.43$10.09+7.00%$10.10$9.191.88 million shs$1.18 billion11/18/2024$9.26$9.43+1.84%$9.46$8.981.96 million shs$1.10 billion Related Companies LEGN Stock Chart NUVL Stock Chart BPMC Stock Chart ELAN Stock Chart CYTK Stock Chart TGTX Stock Chart VKTX Stock Chart BBIO Stock Chart CRNX Stock Chart KRYS Stock Chart Receive ARQT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARQT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcutis Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
